Biotech YolTech Therapeutics to Initiate a Clinical Trial for YOLT-204, a First-in-Class Bone Marrow-Targeted In Vivo Gene Editing Therapy for β-Thalassemia January 21, 2025
Biotech Nanoscope Therapeutics to Present at the 21st Annual Advanced Therapies Week Conference January 21, 2025
Search
